Gan & Lee Pharmaceuticals has established a standardized and transparent corporate governance system, resulting in a governance structure in which the shareholders' meeting, the Board of Directors, and the management have clearly defined powers and responsibilities, operate in coordination, and provide effective checks and balances in strict accordance with the "Company Law", the "Securities Law", and regulatory requirements for listed companies. The Board of Directors has established four specialized committees: Strategy, Audit, Nomination, and Remuneration and Assessment.

The company has optimized and adjusted its governance structure in accordance with the law. It abolished the Board of Supervisors, with the Audit Committee assuming supervisory responsibilities. All members of the Audit Committee are non-executive directors, and independent directors constitute more than half of its members, ensuring efficient synergy between decision-making and supervision. The company maintains its independence from its controlling shareholder in terms of business, personnel, assets, organization, and finance. There are no instances of misappropriation of funds by the controlling shareholder or similar circumstances.

The company is committed to protecting the legitimate rights and interests of shareholders and creating long-term value for them through transparent and efficient corporate governance.